2022, November, Lisbon/Prague
Leeaf among Top 200 companies to watch at Websummit 2022
We are greatly honoured that Leeaf was recognised as one of the Top 200 companies to watch during the 2022 Websummit in Lisbon, Portugal.
Among 2 296 attending start-ups we were recognized as one of the most aspiring companies to watch and invited to an exclusive networking event, the Gathering, to meet with with like-minded tech enthusiasts and entrepreneurs.
To us, this recognition confirms that our hard work and the every-day effort that we put into developing our solution pays off and that we are headed into the right direction.
It has been an honor to receive such recognition for our data-driven fertility health platform and we will continue building our efficient decision supportive tool to guide patients globally on their fertility journey and support physicians in treatment selection.
In the meantime, we hope to meet many of you at the Fertility Conference - Reproduction in an aging world in Belfast, UK in January 11th-14th 2023.
Follow Leeaf on social media and subscribe to our newsletter to stay in touch and informed!
2021, October, London/Prague
Partnership between the European Fertility Society and Leeaf
PRAGUE (Oct, 2021): We are pleased to announce the formed partnership between the European Fertility Society (www.europeanfertilitysociety.com) and Leeaf. The focus of this partnership is to create an educational platform for patients and physicians to derive from rich, diverse and clinical lifestyle data that is being processed by algorithms and the latest advances in AI (artificial intelligence) technologies. AI has made significant advances over the last years; specifically in the healthcare sector with use cases ranging from medical image recognition to AI supported diagnostic tools. Leeaf is taking it a step further with AI, prescribing hyper personalized treatments for IVF patients that serve as transparent and explainable decision supporting tool for IVF physicians. It is also hyper personalized for physician and clinics to ensure real life situations are taken into account.
2020, December, London
Leeaf Established Its UK Subsidiary
LONDON (Dec 2020): Leeaf established its UK subsidiary to serve UK patients and clinics with an AI-powered IVF platform. “Our market tests last year indicated that UK patients are not only in need of but also actively searching for novel approaches to solving their infertility challenges. Strong competition among UK IVF centres seems to provide a vibrant and open environment for progressive, evidence-based approaches and conducting high-quality research in the field of IVF. These two reasons lead us to prioritize the UK market, and we are humbled and excited at the same time about this strategic move,” said Jan Choma, Leeaf’s founder and CEO.
2020, December, Prague
Leeaf Secures a $750,000 Seed Investment To Fund The Development Of The IVF Platform Powered By AI.
PRAGUE (Dec 2020): Leeaf announced a $750,000 investment from a group of private investors to fund the IVF platform's development powered by AI.
"We are excited to be able to move forward with our IVF platform development," said Jan Choma, Founder and CEO of Leeaf. "This investment will help accelerate the process of bringing individualized, AI-supported fertility treatments to women who are struggling with fertility issues."
The Leeaf Fertility Platform will combine the power of data-driven medicine with the ease of use of today’s mobile applications to provide individualized treatment options and conception plans to the community of women looking to take control of their fertility. The iOS and Android mobile application will provide powerful real-time insights for women, clinicians, and fertility researchers to improve outcomes and build healthy families.
As the use of ever more powerful sensors provides health data at a scale that was inconceivable just a short time ago, so too are technologies such as machine learning and AI showing us the way to understand and utilise this data to produce more predictive, more personalised and simply more effective treatments. Leeaf is the trusted bridge between the patients, doctor and data.
"It is great to have a partner who understands the value of Leeaf's Fertility platform and the good this work will do for women and families across Europe and around the world," added Choma.
GROW YOUR CLINIC WITH LEEAF
If you are interested in becoming part of a rapidly evolving, therapeutic, transformative and life changing ecosystem, we invite you to become part of the conversation.